PUBLISHER: The Business Research Company | PRODUCT CODE: 1750944
PUBLISHER: The Business Research Company | PRODUCT CODE: 1750944
Cold and flu supplements are dietary products designed to support the immune system and help relieve symptoms associated with colds and the flu. They are commonly used to boost immunity, reduce congestion, soothe sore throats, and aid in overall recovery.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
These supplements primarily include vitamins and minerals, herbal extracts, and natural molecules. Vitamins and minerals are vital nutrients that contribute to key bodily functions such as immune support, energy production, and cell repair. They are available in various forms, including tablets and capsules, powders, syrups, and others, and are distributed through multiple channels such as pharmacies and drug stores, hypermarkets and supermarkets, online platforms, and other outlets.
The cold and flu supplements market research report is one of a series of new reports from The Business Research Company that provides cold and flu supplements market statistics, including the cold and flu supplements industry global market size, regional shares, competitors with the cold and flu supplements market share, detailed cold and flu supplements market segments, market trends, and opportunities, and any further data you may need to thrive in the cold and flu supplements industry. These cold and flu supplements market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The cold and flu supplements market size has grown rapidly in recent years. It will grow from$19.98 billion in 2024 to $22.63 billion in 2025 at a compound annual growth rate (CAGR) of 13.2%. The growth during the historic period can be attributed to an increasing aging population, a rise in flu cases, enhanced government support, growing consumer purchasing power, and increased spending on products that boost immune health.
The cold and flu supplements market size is expected to see rapid growth in the next few years. It will grow to$36.82 billion in 2029 at a compound annual growth rate (CAGR) of 12.9%. The growth anticipated in the forecast period can be attributed to the rising incidence of respiratory infections, an increasing burden of seasonal influenza, growing demand for immune support supplements, heightened awareness of the benefits of dietary supplements, and a rising preference for natural and plant-based herbal extracts. Key trends expected during this period include innovative product formulations, the emergence of personalized medicine, development of targeted solutions, and advances in nutritional sciences.
The increasing incidence of seasonal diseases is expected to boost the growth of the cold and flu supplements market in the coming years. Seasonal diseases are ailments that occur more frequently during specific times of the year, often influenced by changes in weather, climate, or environmental conditions. The rising occurrence of these illnesses is largely attributed to climate change, which disrupts temperature and humidity patterns, thereby extending transmission seasons and facilitating the spread of viruses such as influenza. Cold and flu supplements contribute to managing seasonal illnesses by boosting immunity, minimizing symptom severity, and promoting quicker recovery. For example, in January 2025, the Nippon Communications Foundation, a Japan-based non-profit organization, reported that influenza cases in Japan surged to a record 317,812 in December 2024. Additionally, in November 2023, the Bureau of Labor Statistics, a US-based government agency, noted that the illness rate among private industry employees rose to 45.2 cases per 10,000 full-time equivalent workers in 2022, up from 37.7 cases in 2021. As a result, the growing frequency of seasonal diseases is fueling demand for cold and flu supplements.
Leading players in the cold and flu supplements market are innovating with products such as all-in-one multi-symptom remedies to provide comprehensive symptom relief in a single dose, improving both convenience and efficacy for consumers. These all-in-one formulations are designed to simultaneously alleviate various cold and flu symptoms-including congestion, cough, fever, and body aches-offering a holistic solution. For instance, in January 2024, Reckitt Benckiser Group plc, a UK-based health, hygiene, and nutrition company, launched Fast-Max Kickstart, a new product aimed at delivering fast relief for morning cold and flu symptoms. The formulation features rapid-acting ingredients that effectively ease congestion, sore throat, and body aches, helping consumers start their day more comfortably. Its distinct cooling sensation also offers a refreshing effect while soothing irritation.
In September 2023, Sanofi S.A., a France-based pharmaceutical firm, acquired Qunol LLC for $1.4 billion. This acquisition is part of Sanofi's strategy to enhance its consumer healthcare portfolio by increasing its footprint in the wellness and dietary supplements sector. By integrating Qunol's widely recognized brand-particularly known for products supporting heart health and immune function-Sanofi aims to capitalize on growing demand for preventive health solutions, including those that assist in managing cold and flu symptoms. Qunol LLC is a US-based producer of immune support supplements geared toward reducing the impact of cold and flu ailments.
Major players in the cold and flu supplements market are Pfizer Inc., The Procter & Gamble Company, Johnson & Johnson, Bayer AG, Sanofi SA, Reckitt Benckiser Group plc, Haleon plc, Perrigo Company plc, Amway Corporation, Nu Skin Enterprises Inc., The Vitamin Shoppe Inc., NOW Health Group Inc., Nature's Sunshine Products Inc., Nature's Way Products LLC, Nordic Naturals Inc., Orthomol GmbH, Weefsel Pharma Pvt. Ltd., AdvaCare Pharma USA, Zarbee's Naturals LLC, and Neurobiologix Inc.
North America was the largest region in the cold and flu supplements market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in cold and flu supplements report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the cold and flu supplements market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The cold and flu supplements market consists of sales of effervescent tablets, lozenges, herbal teas, and nasal sprays. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Cold And Flu Supplements Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on cold and flu supplements market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for cold and flu supplements ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The cold and flu supplements market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.